12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 02/11 21:05
Gainers
- AirSculpt Technologies (NASDAQ:AIRS) stock increased by 11.8% to $2.37 during Wednesday's after-market session. The company's market cap stands at $135.4 million.
- EUDA Health Holdings (NASDAQ:EUDA) shares rose 6.88% to $0.93. The market value of their outstanding shares is at $45.7 million.
- GridAI Technologies (NASDAQ:GRDX) stock rose 5.44% to $3.3. The company's market cap stands at $9.1 million.
- HCW Biologics (NASDAQ:HCWB) shares moved upwards by 5.01% to $1.04. The company's market cap stands at $3.3 million.
- Atossa Therapeutics (NASDAQ:ATOS) shares moved upwards by 4.55% to $4.23. The market value of their outstanding shares is at $41.5 million.
- iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 4.54% to $0.43. The market value of their outstanding shares is at $7.3 million.
Losers
- Vanda Pharmaceuticals (NASDAQ:VNDA) stock decreased by 10.1% to $6.68 during Wednesday's after-market session. The market value of their outstanding shares is at $438.4 million. As per the news, the Q4 earnings report came out today.
- Catheter Precision (AMEX:VTAK) stock decreased by 8.21% to $1.79. The company's market cap stands at $3.3 million.
- Galecto (NASDAQ:GLTO) shares fell 7.8% to $20.1. The market value of their outstanding shares is at $34.4 million.
- Aspire Biopharma Hldgs (NASDAQ:ASBP) shares declined by 7.41% to $1.25. The company's market cap stands at $5.6 million.
- NeOnc Technologies Hldgs (NASDAQ:NTHI) stock decreased by 6.7% to $10.03. The market value of their outstanding shares is at $256.9 million.
- PRF Technologies (NASDAQ:PRFX) shares declined by 4.07% to $3.07. The company's market cap stands at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.